Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07645222
PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLCHansoh BioMedical R&D CompanyNot Yet RecruitingPhase 1
NCT07645222Not Yet Recruiting
Phase 1
PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLCHansoh BioMedical R&D Com...
NCT07644286
A Phase II Study of Pirfenidone Plus PD-1 Inhibitor With or Without Hypofractionated Radiotherapy for Refractory pMMR/MSS Colorectal CancerTao ZhangRecruitingPhase 2
NCT07644286Recruiting
Phase 2
A Phase II Study of Pirfenidone Plus PD-1 Inhibitor With or Without Hypofraction...Tao Zhang
NCT07643922
Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid HemorrhageBeijing Tiantan HospitalNot Yet RecruitingNot Applicable
NCT07643922Not Yet Recruiting
Not Applicable
Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorr...Beijing Tiantan Hospital
NCT07645586
A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic StrokeBeijing Tiantan HospitalNot Yet RecruitingPhase 3
NCT07645586Not Yet Recruiting
Phase 3
A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After A...Beijing Tiantan Hospital
NCT07643831
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2- Early or Locally Advanced/Metastatic Breast CancerGenentech, Inc.Unknown
NCT07643831Unknown
—
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2-...Genentech, Inc.
NCT07646288
Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After LobectomyHacettepe UniversityRecruitingNot Applicable
NCT07646288Recruiting
Not Applicable
Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After Lobe...Hacettepe University
NCT07646171
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)Tel-Aviv Sourasky Medical CenterRecruiting
NCT07646171Recruiting
—
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+)...Tel-Aviv Sourasky Medical...
NCT07644052
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use DisorderPleoPharma, Inc.RecruitingPhase 3
NCT07644052Recruiting
Phase 3
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cann...PleoPharma, Inc.
NCT07643779
Symptom Severity, Posture, Pain, and Physical Activity in Gastroesophageal Reflux DiseaseKarabuk UniversityNot Yet Recruiting
NCT07643779Not Yet Recruiting
—
Symptom Severity, Posture, Pain, and Physical Activity in Gastroesophageal Reflu...Karabuk University
NCT07644468
Visual Rehabilitation in Children With Autism Spectrum Disorder and Visual DisordersNational Taiwan University HospitalCompletedNot Applicable
NCT07644468Completed
Not Applicable
Visual Rehabilitation in Children With Autism Spectrum Disorder and Visual Disor...National Taiwan Universit...
NCT07645131
Development of a Mobile Health Intervention to Support Functioning of Veterans With Substance Use DisordersVA Office of Research and DevelopmentNot Yet RecruitingNot Applicable
NCT07645131Not Yet Recruiting
Not Applicable
Development of a Mobile Health Intervention to Support Functioning of Veterans W...VA Office of Research and...
NCT07645937
Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Morphology in Individuals With Relapsing-Remitting Multiple SclerosisDicle UniversityNot Yet RecruitingNot Applicable
NCT07645937Not Yet Recruiting
Not Applicable
Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Mor...Dicle University
NCT07644403
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.Suzhou Immunofoco Biotechnology Co., LtdEnrolling By InvitationPhase 1
NCT07644403Enrolling By Invitation
Phase 1
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid...Suzhou Immunofoco Biotech...
NCT07643987
Diagnosis of Gestational Diabetes Based on a 50-gram Glucose ChallengeMethodist Health SystemCompleted
NCT07643987Completed
—
Diagnosis of Gestational Diabetes Based on a 50-gram Glucose ChallengeMethodist Health System
NCT07645118
Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal CancerDr. Te VuongNot Yet RecruitingPhase 2
NCT07645118Not Yet Recruiting
Phase 2
Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal CancerDr. Te Vuong
NCT07645105
Body Weight Reduction and Metabolic/Biochemical Parameters in Overweight or ObesityMedical University of SilesiaCompleted
NCT07645105Completed
—
Body Weight Reduction and Metabolic/Biochemical Parameters in Overweight or Obes...Medical University of Sil...
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07644416
Using Virtual Reality Travel to Reduce Loneliness in Older AdultsIndiana UniversityNot Yet RecruitingNot Applicable
NCT07644416Not Yet Recruiting
Not Applicable
Using Virtual Reality Travel to Reduce Loneliness in Older AdultsIndiana University
NCT07645859
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuous Training in Chronic Non-Specific Low Back Pain PatientsDow University of Health SciencesRecruitingNot Applicable
NCT07645859Recruiting
Not Applicable
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuou...Dow University of Health...
NCT07645313
Accuracy and Safety of Anytime 5Pro and Anytime 4Pro CGM Systems in Adults With DiabetesJiangsu Yuwell POCTech Biotechnology Co., Ltd..Not Yet RecruitingNot Applicable
NCT07645313Not Yet Recruiting
Not Applicable
Accuracy and Safety of Anytime 5Pro and Anytime 4Pro CGM Systems in Adults With...Jiangsu Yuwell POCTech Bi...
Result Breakdown
Not yet recruiting9 (45%)
Recruiting6 (30%)
Completed3 (15%)
Unknown1 (5%)
Enrolling by invitation1 (5%)
not_applicable8 (40%)
Not Specified5 (25%)
Phase 23 (15%)
Phase 12 (10%)
Phase 32 (10%)